ProText Mobility Inc (TXTM)

[La Dolce Vita]

Based on this $TXTM Press, and upon what the minutes 'should' corroborate, medicinal marijuana legislation has been finalized/approved.

The Medicines Act and the MCC's Guidelines have been adopted by #SA Parliament, and so now the legal framework/infrastructure to begin the issuance of Permits & Licenses has been implemented, choo-choo.

https://www.iol.co.za/sundayindependent/analysis/medical-marijuana-bill-rejected-but-12157890

Sections 22A (9)(i) and 21 enable the use of an unregistered drug under specific conditions with permission from the director-general of the Health Department. A valid medical reason for requiring cannabis use for therapeutic effects is necessary. The application form is available on the website of the MCC.

Cannabidiol (or more commonly known as CBD or dagga oil) is rescheduled as a Schedule 4 substance. This means that you can obtain the medicine with a prescription from a medical practitioner only.

Section 22C(1)(b) of the Medicines Act makes provision for the cultivation and growing of cannabis; manufacturing; importation; exportation; and distribution of cannabis-containing medicines. The MCC has developed guidelines for growing cannabis for medicinal and research purposes.

The aim is to provide minimum operating procedures relating to the cultivation of cannabis and manufacture of cannabis-related pharmaceutical products.

Licensed domestic cultivation of medicinal cannabis will be aimed at ensuring the supply of a standardized, quality-assured product for medical, scientific and clinical research purposes, and the implementation of control measures necessary to prevent misuse and to ensure patient safety.

Cannabis grown or cultivated for medicinal purposes, as well as any resulting products prepared from the plant material, will remain subject to stringent security and quality control measures.

The departments of Health and Agriculture and the SAPS are working together to look at the commercial suitability growing of hemp in South Africa. This is an ongoing process.

During its briefing to the committee, the MCC undertook to have an open-door policy to stakeholders, particularly in the evaluation of applications from growers. A working group for evaluations has been established between the departments of Health and Agriculture.

The MCC has emphasised that there will be an ongoing review of applications for research and medicinal use.